Clinical trials
Active, not recruiting Hyperlipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| NewAmsterdam Pharma | 2 |
| Brigham and Women's Hospital | 1 |
| Duke University | 1 |
| Johns Hopkins University | 1 |
| Madrigal Pharmaceuticals, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Pichamol Jirapinyo, MD, MPH | 1 |
| University of Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 15 |
| Diabetes Mellitus, Type 2 | 4 |
| Dyslipidemias | 4 |
| Atherosclerosis | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Hypercholesterolemia | 3 |
| Hypertension | 3 |
| Obesity | 3 |
| Stroke | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.